Concepedia

Author

Fatemeh G. Amlashi

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

F.G. Amlashi, Fatemeh G Amlashi, Fatemeh G. Amlashi, Fatemeh Ghazanfari Amlashi, Fatemeh G. Amlashi

32

Publications

753

Citations

11

H-Index

10

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterMassachusetts General HospitalKumamoto UniversityHarvard University
FG

About

Fatemeh G. Amlashi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

37

2

Gastroenterology

2

2

21

3

Emergency Medicine

1

1

10

4

Pathology

1

1

16

5

Surgical Oncology

1

1

11

Fatemeh G. Amlashi

×

11

Publications

584

Citations

10

H-Index

YearCitations

Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas MD Anderson Cancer Center experience

Mariela Blum Murphy, Lianchum Xiao, Viren Patel,

Cancer

2017

189

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response

Ruiping Wang, Shumei Song, Kazuto Harada,

Gut

2019

168

Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease

Fatemeh G. Amlashi, Brooke Swearingen, Alexander T. Faje,

The Journal of Clinical Endocrinology & Metabolism

2015

66

Bone microarchitecture and estimated bone strength in men with active acromegaly

Paula P B Silva, Fatemeh G. Amlashi, Elaine W Yu,

European Journal of Endocrinology

2017

46

Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma

Graciela M. Nogueras‐González, Kazuto Harada, Fatemeh G. Amlashi,

Journal of Surgical Oncology

2017

28

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy

Xuemei Wang, Kazuto Harada, Mariela A. Blum Murphy,

Oncology

2017

18

Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation

Kazuto Harada, Carol C. Wu, Xuemei Wang,

Annals of Surgery

2019

17

Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial

Kazuto Harada, Xuemei Wang, Yusuke Shimodaira,

Targeted Oncology

2017

16

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

Yusuke Shimodaira, Rebecca Slack, Kazuto Harada,

British Journal of Cancer

2017

15

Potentially curable gastric adenocarcinoma treated without surgery

Graciela M. Nogueras-Gonzáles, Kazuto Harada, Fatemeh G. Amlashi,

European Journal of Cancer

2018

11

Page 1